|
|
Volumn 16, Issue 15, 2008, Pages 7510-7515
|
|
Novel sterically hindered cannabinoid CB1 receptor ligands
|
|
Author keywords
Antagonist; Cannabinoid; CB1; CB2; Endocannabinoid; Inverse agonist; Receptor; Rimonabant
|
|
Indexed keywords
2 (4 AMINOPHENYL) 2 PHENYL N (3,3 DIPHENYLPROPYL)ACETAMIDE;
2 (4 BROMOPHENYL) 2 PHENYL N (3,3 DIPHENYLPROPYL)ACETAMIDE;
2 (4 CHLOROPHENYL) 2 PHENYL N (3,3 DIPHENYLPROPYL)ACETAMIDE;
2 (4 HYDROXYPHENYL) 2 PHENYL N (3,3 DIPHENYLPROPYL)ACETAMIDE;
2 (4 METHOXYPHENYL) 2 PHENYL N (3,3 DIPHENYLPROPYL)ACETAMIDE;
2 (4 METHYLPHENYL) 2 PHENYL N (3,3 DIPHENYLPROPYL)ACETAMIDE;
2 (4 NITROPHENYL) 2 PHENYL N (3,3 DIPHENYLPROPYL)ACETAMIDE;
2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE;
5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CYCLIC AMP;
FORSKOLIN;
LIGAND;
N (3 PHENYL)PROPYL 2 (4 BROMOPHENYLACETAMIDE);
N (3 PHENYL)PROPYL 2 (4 CHLOROPHENYL) 2 PHENYLACETAMIDE;
N (3 PHENYL)PROPYL 2,2 DIPHENYLACETAMIDE;
N (3,3 DIPHENYL)PROPYL 2 (4 BROMOPHENYL)ACETAMIDE;
N (3,3 DIPHENYL)PROPYL 2 (4 CHLOROPHENYL)ACETAMIDE;
N (3,3 DIPHENYL)PROPYL 2 CHLORO 2,2 DIPHENYLACETAMIDE;
N (3,3 DIPHENYL)PROPYL 2 HYDROXY 2,2 DIPHENYLACETAMIDE;
N (3,3 DIPHENYL)PROPYL 2 METHYL 2,2 DIPHENYLACETAMIDE;
N (3,3 DIPHENYL)PROPYL 2 PHENYLACETAMIDE;
N (3,3 DIPHENYL)PROPYL 2,2 DIPHENYLACETAMIDE;
RIMONABANT;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
BINDING AFFINITY;
CELL LINE;
DRUG DESIGN;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
MOUSE;
NEUROBLASTOMA CELL;
NONHUMAN;
ACETAMIDES;
ANIMALS;
CELL LINE, TUMOR;
LIGANDS;
MICE;
MOLECULAR STRUCTURE;
RECEPTOR, CANNABINOID, CB1;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 48449103061
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2008.06.001 Document Type: Article |
|
Times cited : (17)
|
|
References (24)
|
